NCT06180590View on ClinicalTrials.gov

The Efficacy of Vosevi in Treating DAA-experienced Patients

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

February 28, 2023

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2027

Conditions
Chronic Hepatitis CMedication Reaction
Interventions
DRUG

Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi]

Evaluate the efficacy of Vosevi in DAAs-experienced patients

Trial Locations (1)

Unknown

RECRUITING

The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
lead

The Third Affiliated Hospital of Guangzhou Medical University

OTHER